glp-1 lasker 2024 Lasker-DeBakey Clinical Medical Research Award winner Svetlana Mojsov describes her discovery of glucagon-like peptide (GLP)-1, the biologically active incretin that led to development of effective analogues for diabetes and obesity 2024 Lasker Awards - Richard
Description
professional input
Impaired absorption of insulin aspart
Karakasis et al
By 2022, that had more than quadrupled to $2.21 PMPM
But even with hundreds of thousands of new prescriptions every year, the widespread incidence of both diabetes and obesity means there is a lot more room to run
